prognocis meaningful use guidelines

57
PrognoCIS™ EMR Meaningful Use Training For process training, please contact our training department at (727) 238-3367 or email us at [email protected] . For Meaningful Use properties/configuration, please email us at [email protected] .

Upload: kay-mercado

Post on 03-Dec-2014

50 views

Category:

Documents


0 download

DESCRIPTION

PrognoCIS™ EMRMeaningful Use TrainingFor Meaningful Use properties/configuration, please email us at [email protected]. For process training, please contact our training department at (727) 238-3367 or email us at [email protected] Bullets• Q&A will follow the presentation– Please save your questions until the end• Some features are dependent upon certain settings and configuration you will have to f/up with Bizmatics– 1-on-1 Meaningful Use Implementation sessio

TRANSCRIPT

Page 1: Prognocis Meaningful Use Guidelines

PrognoCIS™ EMR

Meaningful Use Training

For process training, please contact our training department at (727) 238-3367 or email us at [email protected].

For Meaningful Use properties/configuration, please email us at [email protected].

Page 2: Prognocis Meaningful Use Guidelines

Housekeeping Bullets • Q&A will follow the presentation

– Please save your questions until the end

• Some features are dependent upon certain settings and configuration you will have to f/up with Bizmatics – 1-on-1 Meaningful Use Implementation session after this webinar

– Email: [email protected]

• Please mute your phones or laptop speakers – On GTM Navigation Toolbar, click the microphone ( ) or the Mute All

button ( )

– On telephone, click the Mute button

– Remember to un-mute for Q&A

Page 3: Prognocis Meaningful Use Guidelines

The Medicare EHR Incentive Program for Eligible Providers (EP) runs from 2011 – 2016. For 2011, EP’s must demonstrate meaningful use for a 90 consecutive day reporting period. EP’s can participate for the entire duration of 5 years within this time span.

Medicare Meaningful Use

CMS Requirements: • Register for the EHR Incentive Program • Meet meaningful use criteria for 90 consecutive days during 2011

• Subsequent years will require an entire year of compliant data • Attest using CMS web-based system by keying in numerator/denominator values

PrognoCIS Requirements • Upgrade EMR to v2b2 (CCHIT-certified) or higher • Notify [email protected] to enable your properties, eRx, and Rx-hub • Weekly tracking via reports and dashboards

https://www.cms.gov/EHRIncentivePrograms/35_Basics.asp#TopOfPage

• Maximum reimbursement for 5-year period is $44,000 • EP must have incurred minimum revenue $24,000 in given year • EP who also qualify for Medicaid must choose one or the other

Medicare EHR Payment Schedule for EP’s:

Page 4: Prognocis Meaningful Use Guidelines

The Medicaid EHR Incentive Program for Eligible Providers (EP) runs from 2011 – 2021. States and territories can voluntarily offer the Medicaid EHR program. EP’s can partici- pate for a duration of 6 years within this time span.

Medicaid Meaningful Use

CMS Requirements: • Register for the EHR Incentive Program • Adopt & implement a meaningful-use certified EHR system within the practice

• 2011 has not specific number of days; otherwise entire year of data is required. • Attest using CMS web-based system by keying in numerator/denominator values

PrognoCIS Requirements • Upgrade EMR to v2b2 (CCHIT-certified) or higher • Notify [email protected] to enable your properties, eRx, and Rx-hub • Weekly tracking via reports and dashboards

https://www.cms.gov/EHRIncentivePrograms/35_Basics.asp#TopOfPage

Medicaid EHR Payment Schedule for EP’s:

• Maximum reimbursement for 6-year period is $63,750 • EP must have a minimum of 30% Medicaid-eligible patient population • EP who also qualify for Medicare must choose one or the other

Page 5: Prognocis Meaningful Use Guidelines

Eligible Providers (EP) http://www.cms.gov/EHRIncentivePrograms/15_Eligibility.asp#TopOfPage

To verify requirements of eligibility, please go to the above link. There is also a link to Frequently Asked Questions (FAQ’s) to elaborate on the conditions of eligibility for each program. A provider who is hospital-based cannot qualify for the program. If your practice has multiple providers, each provider may individually register and attest for his/her own incentive.

MD, DO but not ARNP, PA

Page 6: Prognocis Meaningful Use Guidelines

Registration Links: https://ehrincentives.cms.gov/hitech/login.action http://www.youtube.com/user/CMSHHSgov?feature=mhum#p/u/0/sKngNjd8Iuc

PrognoCIS™ EHR Certification Number: https://onc-chpl.force.com/ehrcert (e.g.: 30000001SWUGEAS) Note: A unique Certification Number will be generated for each EP.

Registration for EHR Incentive

Some Important Dates: • January 3, 2011 earliest registration for eligible providers (EP) • April 18, 2011 earliest eligible date to begin attestation • October 1, 2011 last day to begin 90-day Reporting Period • February 29, 2012 last day for eligible providers to register and attest to receive incentive payment for 2011

CMS Home Page for EHR Incentive Programs: http://www.cms.gov/EHRIncentivePrograms/60_RegulationsNotices.asp

Our clients are already receiving ARRA reimbursements regularly!

Page 7: Prognocis Meaningful Use Guidelines

The 90-Day Reporting Period The date on which an Eligible Provider actually registers for the EHR Incentive Program with CMS has no bearing on the 90-days selected to gather the data. As soon as you have implemented your EHR, you can start gathering data for any desired period of 90 consecutive days. You may register at any time even if you have already begun gathering your data. As you complete your attestation with CMS, then you will actually declare the specific 90-days you chose. The attestation data that you enter at that time must reflect those 90-days.

Medicare-only requirement

Page 8: Prognocis Meaningful Use Guidelines

Documentation Conventions

Exclusion: Any EP who…

Measure 1 %-Y/N

Encounter TOC a

• - denotes the required value you must enter on CMS when doing your attestation. – * Y / N = yes or no PrognoCIS provides the faculty

– * %’s = numerator (value) must be entered

• - denotes who can be excluded from reporting on this measure; or lists additional references qualifying data, or relevant properties.

• - denotes the screen or menu option within PrognoCIS where the measure occurs; or lists required properties/additional references.

• - denotes extra/qualifying information or training steps relevant to the PrognoCIS requirements for compliance with the measure.

• - denotes icon or field of relevance on screen inside PrognoCIS.

• - denotes an important FYI/remark

Page 9: Prognocis Meaningful Use Guidelines

Core Measures

• Use CPOE for entering medication orders • Drug/drug and drug/allergy Interaction checks • Maintain up-to-date problem list of current/active diagnoses • E-prescribing of permissible prescriptions • Maintain active medication list • Maintain active medication allergies list • Record specific defined demographics • Record and chart specific defined vital signs • Record smoking status for patients 13 years or older • Report ambulatory clinical quality measures to CMS or to the state • Implement at least 1 clinical decision support rule for specialty & track it • Provide patients with an electronic copy of their health information • Provide patients with clinical summaries for each visit • Sharing of key clinical information amongst care providers & other agencies • EHR technical security to protect electronic health information

http://www.cms.gov/EHRIncentivePrograms/Downloads/EP-MU-TOC.pdf

15 Mandatory

Page 10: Prognocis Meaningful Use Guidelines

CPOE (Computerized Physician Order Entry)

Exclusion: Any EP who writes fewer than 100 prescriptions during the 90-day reporting period.

Encounter TOC a Prescription CPOE a Rx

Measure 1 %’s

More than 30% of all unique patients with at least 1 medication order must have the prescription entered using CPOE in a digital, structured format directly into the medical record by a licensed healthcare professional.

This measure does not consider the method of transmission or getting the Rx to the pharmacy. It is based solely on entering the drug details.

Page 11: Prognocis Meaningful Use Guidelines

The EP must implement drug-drug and drug-allergy interaction checking for the entire reporting period. Note: The measure does not require that indications exist.

Drug Interaction Validation

Prescription a Update Drug rx.check.drugdiseaseinteraction; rx.check.drugdruginteraction

rx.drugdiseaseinteraction.severitylevel; rx.drugdruginteraction.severitylevel

Measure 2 Y / N

This feature can be disabled at a later time; however, it must be enabled during the entire reporting period of meaningful use.

Page 12: Prognocis Meaningful Use Guidelines

Problem List of Diagnoses

Face Sheet a Past Medical History facesheet.explicit.review

More than 80% of all unique patients seen by an EP, maintain at least one entry or an indication that no problems are known as structured data.

Measure 3 %’s

A list of current and active as well as past diagnoses relevant to the current care of the patient. The provider must keep this list up to date.

Do not leave blank as

regards ICD

Physician can auto-populate ICD to PMH from Assessment as applicable.

Page 13: Prognocis Meaningful Use Guidelines

More than 40% of all permissible prescriptions* written by EP are transmitted

electronically using EHR technology.

e-Prescribing

Exclusion: Any EP who writes fewer than 100 prescriptions during the 90-day reporting period.

Prescription a eRx icon http://www.deadiversion.usdoj.gov/schedules/orangebook/e_cs_sched.pdf

Measure 4 %’s

eRx indicator for Pharmacy

and Drug*

(MU Denominator) All prescriptions written during the reporting period.

(MU Numerator) All permissible eRx drugs that were ordered eRx.

Page 14: Prognocis Meaningful Use Guidelines

More than 80% of all unique patients seen by EP, maintain at least one entry (or an indication that that patient is not currently prescribed any medication) recorded as structured data.

Medication List

Face Sheet a Current Medication facesheet.explicit.review

Measure 5 %’s

Do not leave blank

The EP is not required to update this list at every contact with the

patient and can update it at his/her clinical discretion.

Drug details are not required (e.g.: Dose, Frequency, etc.).

Page 15: Prognocis Meaningful Use Guidelines

Medication Allergy List

Face Sheet a Allergy facesheet.explicit.review; patient.set.noknown.flags

Measure 6 %’s

More than 80% of all unique patients seen by EP, maintain at least one entry (or an indication that that patient has no known medication allergies) recorded as structured data.

The EP is not required to update this list at every contact with the patient.

Non-medication allergies may also be present; however, the measure requires only that drug allergies be documented.

Do not leave blank as to

Drug Allergies

Page 16: Prognocis Meaningful Use Guidelines

Demographics More than 50% of all unique patients seen by an EP must have all five demographic fields (i.e.: DOB, Gender, Preferred Language, Ethnicity, and Race) recorded as structured data.

Patient Register a Other Info

Measure 7 %’s

http://www.whitehouse.gov/sites/default/files/omb/assets/information_and_regulatory_affairs/re_app-a-update.pdf

“Unknown” or “Patient Refused to Disclose” are acceptable notations when applicable.

Page 17: Prognocis Meaningful Use Guidelines

Vitals History

Encounter TOC a Vitals vital.height.testcode; vital.weight.testcode; vital.bp.testcode

More than 50% of all unique patients 2 years or older seen by an EP, the height, weight, blood pressure, & BMI must be recorded as structured data. Plot and display growth charts for children 2-20 years including BMI.

Exclusion: Any EP who sees no patients 2 years or older, or who believes all 3 vital signs have no relevance in the scope of his or her practice.

Measure 8 %’s

Ht, Wt, & BP must be data-entry BMI will be calculated by EHR Growth chart is not requirement of attestation

Page 18: Prognocis Meaningful Use Guidelines

Smoking Status

Face Sheet a Social History vital.smoking.testcode

More than 50% of all unique patients 13 years or older seen by an EP, must have smoking status recorded as structured data.

Exclusion: Any EP who sees no patients 13 years or older (i.e.: infant-care pediatricians).

Measure 9 %’s

Page 19: Prognocis Meaningful Use Guidelines

Clinical Quality Measures Successfully report ambulatory clinical quality measures selected by CMS in the manner specified by CMS.

Measure 10 %’s

• 44 total Clinical Quality Measures have been defined • EP must report a total (minimum) of 6 (w/a possible maximum of 9^) • 3 mandatory Core measures

• ^If the denominator of 1 = 0, you must chose an alternate > 0 • ^3 Alternate Core CQMs (if needed)

• 38 additional Clinical Quality Measures • Excluding the 3 core/3 alternate core measures • EP must choose 3 of these • “0” is an acceptable denominator value if applicable for the EP

CQM Electronic Specifications

https://www.cms.gov//QualityMeasures/03_ElectronicSpecifications.asp#TopOfPage

CQM Implementation Guide http://www.cms.gov/QualityMeasures/Downloads/QMEPCQMLog.pdf?agree=yes&next=Accept

For future implementation

2012…+...

Page 20: Prognocis Meaningful Use Guidelines

Clinical Quality Measures (cont’d)

https://www.cms.gov/apps/ama/license.asp?file=/QualityMeasures/Downloads/EP_MeasureSpecifications.zip

Measure 10 %’s

Required Core Measures

Report a Tabular a Clinical Quality Measures (The specific measures selected are not defined within PrognoCIS).

NQF0421 = 18-65, BMI last 6 mos. NQF0013 = 18> w/HTN, BP x 2 OV NQF0028 = 18> 2 OV, smoking status

No % requirements

for 2011.

Page 21: Prognocis Meaningful Use Guidelines

Clinical Decision Support Implement one clinical decision support rule relevant to specialty or high clinical priority along with the ability to track compliance with that rule.

Encounter a Expression pop-up (based upon defined trigger)

Role-based login.expression.applicablefor property

Measure 11 Y/N

CMS does not issue guidance as to the specifics for these rules. EP must base them upon work- flow, patient population, and quality improvement efforts.

Page 22: Prognocis Meaningful Use Guidelines

Creating Expressions Clinical Decision Support rules alert the clinician based on the Event and/or HPI Complaint defined to trigger them in conjunction with the conditions defined.

Settings a Configuration a Workflow a Expressions

Measure 11 Y/N

Trigger

Conditions

The Rule

Page 23: Prognocis Meaningful Use Guidelines

Electronic PHI (The Request)

Exclusion: Any EP who has no requests from patients or their agents for an

electronic copy of PHI during the 90-day reporting period.

More than 50% of all patients who request an electronic copy of their health information receive it within 3 business days; at no charge to the patient. Patient requests ePHI (MU Denominator): Messages a Compose Send to designated person within the practice Select Patient *Select Health Information Request Action *Specify Due in Days 3 *Select Add to Patient Medical records check box

Message a Compose

Measure 12 %’s

Diagnostic test results Problem list Medications list Medication allergies

Page 24: Prognocis Meaningful Use Guidelines

Electronic PHI (Processing it) Measure 12 %’s

User generates the ePHI file (MU Numerator):

Messages a Inbox Click Zoom button ( ), which invokes Letters Out screen

If Patient Portal is implemented: The PHI will be available under Visit Summary. Check the Done box in the Inbox.

If no Patient Portal: Letter Template FHR will default Note: If no FHR template is defined, you can select one in the pick list. Click the Attach button Select the Formal Health Record Select Download File icon Assign a password Note: Password must be provided to the patient. Save the encrypted file to your local or server drive File can be copied to thumb drive, burned to CD, or zipped/emailed to the patient. Check the Done box in the Inbox. Message a Inbox

For patient portal, be sure to include email address in Patient Register and assign a User ID/Password to the patient.

Page 25: Prognocis Meaningful Use Guidelines

Electronic PHI (Completing it)

Patient a Letters Out a FHR Property fhr.show must = Y

Measure 12 %’s

Page 26: Prognocis Meaningful Use Guidelines

Clinical Summaries

Encounter TOC a Encounter Close or Patient Portal Define OV codes in arra.ov.cpt.codes property

prognocis.meaningful.summary.template = Summary format allow.directprint.letters = N for Printer Select dialog

Clinical summaries provided to patients for more than 50% of all office visits within 3 business days; at no charge to the patient.

Exclusion: Any EP who has no office visits during the 90-day reporting period.

Measure 13 %’s

MU Summary button n/a when Patient

Portal is active & pt has email or Enc > 3

days old.

Office Visit – a separate billable encounter resulting from E&M services provided to patient as defined in applicable property.

Page 27: Prognocis Meaningful Use Guidelines

Share Key Clinical Info - Export

Capability to exchange key clinical information among providers of care and patient authorized entities electronically. EP must have performed at least 1 test using this feature during the reporting period.

Patient Review a Patient XML

Measure 14 Y/N

Patient a Review Patient XML Enter the patient details Enter the clinic details Export the CCD file

File must be XML – cannot

be PDF.

Diagnostic test results Problem list Medications list Medication allergies

Page 28: Prognocis Meaningful Use Guidelines

Share Key Clinical Info - Export (cont’d)

Once the file is exported, a password (which must be shared with the recipient) must be assigned to encrypt the data.

Patient Review a Patient XML

Assign a password Save the file Note: Based on patient name/export date .exe file.

Copy to thumb drive or CD

Unique legal entities Separate EHR systems Test doesn’t have to be real data

Page 29: Prognocis Meaningful Use Guidelines

Patient Review a CCD/CCR

Share Key Clinical Info - Import Measure 14 Y/N

Patient a Review CCD/CCR Click paper clip icon Browse to the .exe file Click attach button Select the “I” record Enter password The data will display

Capability to exchange key clinical information among providers of care and patient authorized entities electronically. EP must have performed at least 1 test using this feature during the reporting period.

Page 30: Prognocis Meaningful Use Guidelines

Protect Electronic Health Info Protect electronic health information created or maintained by the certified EHR

technology through the implementation of appropriate technical capabilities.

Measure 15 Y/N

FYI – In order to receive our CCHIT certification, PrognoCIS had to pass all such required tests.

FREEBIE!

Page 31: Prognocis Meaningful Use Guidelines

Questions & Answers

15 Core Measures Review

Page 32: Prognocis Meaningful Use Guidelines

Menu Set Measures

5 out of the 10

• Drug Formulary Checks • Clinical Lab Test Results • Patient Lists by Conditions • Patient Reminders • Timely Electronic Access to PHI (Portal only) • Patient-specific education resources • Medication Reconciliation for patients transitioned from other provider of care • Summary of Care Record to other providers of care for patients transitioned • *Submit electronic data to immunization registries • *Submit electronic syndromic surveillance data to public health agencies

http://www.cms.gov/EHRIncentivePrograms/Downloads/EP-MU-TOC.pdf

*Note: One of the 5 optional menu set measures must be either measure #9 or #10.

Your choices do not have to be indicated within PrognoCIS; however, you will indicate those you select during attestation.

Free!

Free!

Page 33: Prognocis Meaningful Use Guidelines

Drug Formulary Checks EP must have enabled this functionality and has access to at least one internal or

external formulary for the entire reporting period.

Exclusion: Any EP who writes fewer than 100 prescriptions during the 90-day reporting period.

Menu Set 1 Y/N

Prescription a enter drug a Update

Freebie! Rx-Hub

required

Page 34: Prognocis Meaningful Use Guidelines

More than 40% of all clinical lab test results ordered by EP using EHR during the reporting period whose results are either positive/negative or numerical format

are incorporated into EHR technology structured data.

Clinical Lab Test Results

Exclusion: An EP who orders no lab tests whose results are either in a positive/negative or numeric

format during the EHR reporting period.

Encounter TOC a Lab Result

Menu Set 2 %’s

Cannot be scanned to

Document List.

(MU Denominator) All Lab Tests ordered during reporting period. (MU Numerator) All Lab Results entered into structured data either by hand or by HL7 interface.

Page 35: Prognocis Meaningful Use Guidelines

Generate at least one report listing patients of the EP with a specific condition to use for quality improvement, reduction of disparities, research, or outreach.

Patient Lists by Condition

Reports a Tabular

Menu Set 3 Y/N

FREEBIE!

Page 36: Prognocis Meaningful Use Guidelines

Patient Reminders More than 20% of all patients 65 years or older or 5 years old or younger were

sent an appropriate reminder (for preventive/f-up care) during the EHR period.

Exclusion: An EP who has no patients 65 years old or older or 5 years old or younger.

Settings a Processes a Appointment Mails

Menu Set 4 %’s

Patients must have a valid email address on Patient Register.

Page 37: Prognocis Meaningful Use Guidelines

Exclusion: Any EP that neither orders nor creates lab tests or information that would be contained in the problem list,

medication list, medication allergy list.

Timely Electronic Access to PHI At least 10% of all unique patients seen by EP are provided timely electronic access (4 business days) to their health information subject to the EP’s discretion to withhold certain information. This includes lab results, problem list, medication lists, and allergies.

Patient Portal (FYI: If you do not have the portal, you

cannot choose this option.)

Menu Set 5 %’s

Patients must have a User ID & Password in order to access the

portal during the 90-days.

Requires Portal.

Page 38: Prognocis Meaningful Use Guidelines

Education Resources More than 10% of all unique patients seen by EP are provided patient-specific education resources, as identified within the EHR.

Encounter TOC a Education Home Page a Check-out Documents

Menu Set 6 %’s

Home Page Select Check-out Docs icon Select ED Type docs

Page 39: Prognocis Meaningful Use Guidelines

The Education Master can be defined to trigger automated or manual addition of educational materials to an encounter based on activity on the chart.

Settings a Configuration a Clinic a Education

Education Master Menu Set 6 %’s

Trigger

Page 40: Prognocis Meaningful Use Guidelines

For more than 50% of patients transitioned into the care of the EP, if the EP believes an encounter is relevant, he should perform a medication reconciliation to identify the most accurate list of medications the patient is taking including dose, frequency, and route by comparing to external documentation of meds.

Medication Reconciliation

Face Sheet a Current Medication a

Menu Set 7 %’s

Exclusion: An EP who was not the recipient of any transitions of care during the reporting period.

(MU Denominator) – all new patients within reporting period. (MU Numerator) – clicking the “H” button then “OK” or “Yes” on the pop-up.

Freebie! Rx-Hub

required

Page 41: Prognocis Meaningful Use Guidelines

Summary of Care Record For more than 50% of patients transitioned from the EP or referred to another provider of care, the EP shall provide a summary care record (electronically) for each transition or referral.

Encounter TOC a Order Sheet a Consults

Exclusion: An EP who neither transfers to another setting of care nor refers to another provider during the reporting period.

Menu Set 8 %’s

Order the Consult (MU Denominator)

EP requests consult on Assessment Consult ordered via Order Sheet Referral generated via Letters Out

Page 42: Prognocis Meaningful Use Guidelines

Summary of Care Record – Letters Out Once the Consult is created, the Summary of Care file can be exported in a XML file to be shared with the other provider or setting of care to which the patient is being transitioned or referred.

Patient a Letters Out

Generate the Referral

Select letter template Assign referring provider Complete the referral letter

Page 43: Prognocis Meaningful Use Guidelines

After the referral is generated, the Continuity of Care Document (CCD) can be generated by exporting it as a password-protected XML file.

Encounter Review a Patient XML

Summary of Care Record – Patient XML

Generate the CCD (MU Numerator) Enter the pertinent details Export the CCD File Assign a password/save it Burn to CD or thumb drive

Page 44: Prognocis Meaningful Use Guidelines

Capability to submit electronic data to immunization registries or immunization information systems; actual submission according to applicable law & practice. EP must have performed at least 1 test of this feature during the reporting period.

Immunization Registries

Encounter Face Sheet a Vaccinations

Exclusion: An EP who administers no immunizations or where no immunization registry has the capacity to receive the information electronically.

Menu Set 9 Y/N

Note: EP must select either Menu Set #9 or #10.

Does your state accept this data electronically?

Page 45: Prognocis Meaningful Use Guidelines

Capability to submit electronic syndromic surveillance data to public health agencies and actual submission according to applicable law and practice. EP must have performed at least 1 test of this feature during the reporting period. .

Settings a Biosurveillance HL7 Export

Syndromic Surveillance

Exclusion: An EP who does not collect any reportable syndromic information on their patients during the reportable period or does not submit such information to any public health agency that has the capacity to receive the information electronically.

Menu Set 10 Y/N

Note: EP must select either Menu Set #9 or #10.

Page 46: Prognocis Meaningful Use Guidelines

Questions & Answers

10 Menu Set Measures Review

Page 47: Prognocis Meaningful Use Guidelines

Meaningful Use Encounter Validation Before closing an encounter, the Encounter Meaningful Dashboard can be viewed to identify compliance at the encounter level.

Encounter Close a Arra Dashboard icon

Note: You may not ever get all green “thumbs-up”, so do not panic! Not all measures will apply at the encounter level.

Sometimes, RED

will be OK!

Page 48: Prognocis Meaningful Use Guidelines

Meaningful Use Tabular Report Use this tabular report to monitor the different Core and Menu Set Measures for which you will be attesting after the 90-day reporting period. These are the values you will enter into CMS when doing your attestation.

Reports a Tabular a Meaningful Use By Provider x 90-day Period

arra.mu.reqd.srnos – by Measure sequence

Numerator – number of patients that meet the criteria Denominator – total number of patients for the 90-days that qualify for the measure (not necessarily compliant) Exclusions may = 0 or be < minimum required.

Page 49: Prognocis Meaningful Use Guidelines

*Meaningful Use Dashboard

prognocis.show.dashboard

Dashboard icon

Page 50: Prognocis Meaningful Use Guidelines

Core Measures Dashboard Graphically displays the 15 mandatory Core Measures with regards to your compliance for each individual measure within the reporting period.

All 15 of these are Required

Remember those measures you are excluding may show “in the red” or =

0, which is acceptable.

Page 51: Prognocis Meaningful Use Guidelines

Menu Set Measures Dashboard Graphically displays the 10 optional Menu Set Measures with regards to your compliance for each individual measure within the reporting period.

Remember these measures are optional, thus those you do not choose may show “in the red”

or = 0, which is acceptable. Choose 5

out of these 10

Page 52: Prognocis Meaningful Use Guidelines

Dashboard Features While viewing the dashboard, shortcut links are available to enable you to easily view the numerator/denominator values as well as detailed definition of each measure. Provider drop-down list allows you to generate

statistics for each individual EP in the practice.

View Details displays a summary of the CMS definition & minimum percentage to qualify.

Tooltip summarizes the numerator and denominator values for the specific measure.

Date Range is the 90-day reporting period.

Page 53: Prognocis Meaningful Use Guidelines

The Attestation to CMS

Any time after you have completed the 90-day reporting period, you can submit your attestation on-line with CMS. During this process, you must key the actual numerical values for each measure (i.e.: “numerator” and “denominator”) and whether or not you are excluding yourself where applicable.

Report a Tabular a Meaningful Use Contact: [email protected]

Our clients are already receiving ARRA reimbursements regularly!

Log in to the CMS Attestation System Select Attestation tab a Attest a Start Attestation button Complete the questionnaire

Enter your EHR Certification & Start/End Dates of 90-day period Enter values for the 15 Core Measures Select then enter values for the optional 5 Menu Set Measures Enter values for the 3 Core Clinical Quality Measures

If numerator of any = 0, report on alternate core CQM as well Select then enter values for the optional 3 Clinical Quality Measures

Review the Summary for completeness Monitor the status until you receive your check!

Page 54: Prognocis Meaningful Use Guidelines

Starting the Attestation w/CMS http://www.cms.gov/EHRIncentivePrograms/Downloads/EP_Attestation_User_Guide.pdf

CMS Registration & Attestation System https://ehrincentives.cms.gov/hitech/login.action

Page 55: Prognocis Meaningful Use Guidelines

http://www.cms.gov/EHRIncentivePrograms/Downloads/EP_Attestation_User_Guide.pdf

The Attestation Questionnaire

Page 56: Prognocis Meaningful Use Guidelines

http://www.cms.gov/EHRIncentivePrograms/Downloads/EP_Attestation_User_Guide.pdf

CMS Registration & Attestation System https://ehrincentives.cms.gov/hitech/login.action

Completing the Attestation w/CMS

Page 57: Prognocis Meaningful Use Guidelines

Ready…Set…Go! Decide on the measures you are going to report on

15 mandatory Core Measures 5 additional Menu Set Measures (out of 10 possible)

Decide the 90-days you will use for your reporting period Implement appropriate workflow/processes to gather the data Register on CMS Complete your attestation on CMS when applicable Collect your reimbursement from the US Government!

Contact us to arrange for your personal Meaningful Use implementation and system configuration by emailing @

[email protected].

Practice name Physician name(s) Name, Phone #,Time Zone